Zejula Copay Assistance

गृह पृष्ठ / Zejula Copay Assistance

अहिले नै आर्थिक राहत पाउनुहोस्

Apply for Zejula Copay Assistance

नि:शुल्क सेवाले तपाईंलाई शीर्ष सह-भुक्तानी सहायता कार्यक्रमहरूसँग मेल खान्छ
आवेदन प्रक्रियाभरि विशेषज्ञहरूले तपाईंलाई सहयोग गर्छन्।
आफ्नो कोष स्थितिमा स्वचालित अद्यावधिकहरू प्राप्त गर्नुहोस्
अहिलेसम्म हाम्रा बिरामीहरूको लागि १TP४४७T५५ मिलियन भन्दा बढी सुरक्षित गरिएको छ।

विशेषज्ञसँग कुरा गर्नुहोस्

सहायता कसरी काम गर्छ

हाम्रो बिरामीको विशेष फार्मेसी अनुभवलाई अतुलनीय पूर्ण-सेवा सुविधाको साथ सुव्यवस्थित गर्दै

१. आफ्नो कभरेज/लाभ प्रमाणिकरण जाँच गर्नुहोस्
हाम्रो विशेषज्ञ बिलरहरूको टोलीले खल्ती बाहिरको लागत कम गर्ने कभरेजको उत्तम तरिकाहरू फेला पार्छ।
२. प्रिस्क्रिप्शन १TP१३५T® मा स्थानान्तरण गर्नुहोस्
हामी तपाईंको अघिल्लो फार्मेसी वा प्रिस्क्राइबरसँग काम गरेर तपाईंको प्रिस्क्रिप्शन प्रशोधन गर्छौं, जसले गर्दा संक्रमण छिटो र सजिलो हुन्छ।
३. पूर्व अनुमतिपत्र
हाम्रो विशेषज्ञहरूको टोलीले तपाईंको बीमा कम्पनीहरूबाट २४ देखि ७२ घण्टा भित्र स्वीकृति प्राप्त गर्दछ।
४. सह-भुक्तानी सहायता र वित्तीय सहायता
हामी आर्थिक सहायता र सह-भुक्तानी घटाउने, खल्तीबाट हुने खर्च, र उच्च कटौतीयोग्य कुराहरू सुरक्षित गर्छौं। आजसम्म, AmeriPharma® स्पेशलिटी केयरले हाम्रा बिरामीहरूको लागि $55 मिलियन आर्थिक सहायता सुरक्षित गरेको छ।
५. आवश्यक परेमा नर्सिङ केयर समन्वय
AmeriPharma® ले तपाईंको घरभित्रको इन्फ्युजनको लागि हाम्रा विशेषज्ञ नर्सहरू मध्ये एकको तालिका र समन्वय गर्दा तपाईंको तालिका र घरको वातावरणलाई प्राथमिकता दिन्छ।
६. डेलिभरी समन्वय
औषधिहरू सधैं ढुवानीको लागि विशेष आवश्यकताहरूको कडाईका साथ डेलिभर गरिन्छ। अर्को दिन र रातभरको कोल्ड-चेन डेलिभरीहरू तपाईंको तालिका वरिपरि समन्वय गरिन्छ।

https://ameripharmaspecialty.com/wp-content/uploads/2024/02/pharmacist.jpg

What Is Zejula?

Zejula (niraparib) is an oral targeted therapy medication used for the treatment of ovarian, fallopian tube, and primary peritoneal cancer. Zejula is a PARP (poly adenosine diphosphate-ribose polymerase) inhibitor that specifically targets cancer cells and exerts less harm on healthy cells in the body. PARP is a protein found in human cells which aids in repairing damaged cells. PARP inhibitors as targeted treatments work by blocking the repair of cancerous cells and allowing them to die.

PARP inhibitors are given to patients after full or partial response to initial chemotherapy with a platinum-based medication. Zejula is used as a maintenance treatment to help prevent cancer from coming back. Zejula is a once-daily oral maintenance medication treatment available in 100 mg capsules that can be taken with or without food.

https://ameripharmaspecialty.com/wp-content/uploads/2024/02/block_image_1.jpg

What is Zejula Used to Treat?

Zejula is FDA approved for adult patients as a maintenance treatment for recurrent maintenance therapy. It is approved for women with advanced ovarian cancer in complete or partial response, such as advanced or recurrent:

Epithelial ovarian cancer
Fallopian tube cancer
Primary peritoneal cancer

Zejula is also used for the treatment of adult patients who have been treated with three or more prior chemotherapy regimens associated with homologous recombination deficiency (HRD) positive status defined by either:

A harmful or suspected-to-be-harmful BRCA mutation, or
A genomic instability that progressed more than 6 months after response to the last chemotherapy session.

https://ameripharmaspecialty.com/wp-content/uploads/2024/05/doctor-patient.jpg

Zejula Side Effects

Zejula Dosing Information

Zejula is only available in 100 mg capsules, and the recommended dosages are shown below:

First-line Maintenance Treatment for Advanced Ovarian Cancer
For patients who weigh < 77 kg (<170 lbs) OR with a platelet count <150,000/ μL, the recommended dose is 200 mg taken by mouth once a day. For patients who weigh >77 kg (>170 lbs) OR with a platelet count >150.000/ μL, the recommended dose is 300 mg taken by mouth once a day.

Maintenance Treatment for Recurrent Ovarian Cancer
The recommended dose is 300 mg (3 capsules) taken orally once daily.

Treatment of Advanced Ovarian Cancer After Three or More Chemotherapy Regimens
The recommended dose is 300 mg (3 capsules) taken orally once daily.
Zejula can be taken with or without food. Take the medication at approximately the same time each day. Taking the medication at bedtime may help relieve symptoms of nausea.

Treatment with Zejula will require routine monitoring of blood pressure, heart rate, and blood cell count.

Continue Zeluja treatment until disease progression or unacceptable toxicity.

It is not known if Zejula is safe and effective in children.

Zejula can cause fetal harm if administered to pregnant patients. Avoid breastfeeding and use effective contraceptives during treatment and for 6 months after the last dose of Zeluja. If you get pregnant, contact your doctor immediately.

Zejula Side Effects

सामान्य साइड इफेक्टहरू समावेश छन्:

मुखमा घाउ हुनु
पेट दुख्ने
कब्जियत वा पखाला
भोक नलाग्नु
Urinary tract infections
Heartburn or indigestion
चिन्ता
घाँटी दुख्ने
सास फेर्न गाह्रो हुनु
दाग लाग्नु

Other side effects of Zejula include:

Musculoskeletal pain
पेट दुख्ने
खोकी
अनिद्रा

गम्भीर साइड इफेक्टहरू समावेश छन्:

Bone marrow suppression: Complete blood counts should be monitored weekly for the first month. Patients should inform their prescribers if any of these symptoms occur:
- कमजोरी
- Feeling tired
- ज्वरो
- Frequent infections
- More bruising or bleeding more easily
- पिसाबमा रगत आउनु

Cardiovascular effects: Blood pressure and heart rate should be monitored at least weekly for the first two months. Patients should inform their prescribers if any of these symptoms occur:
- अनियमित मुटुको धड्कन
- उच्च रक्तचाप
- खोकी
- चक्कर लाग्नु
- वाकवाकी लाग्नु

बीमा स्वीकृत

हामी Medicare, बहु-राज्य Medicaid, Medi-Cal, Blue Shield, र धेरैजसो निजी बीमा स्वीकार गर्छौं। तपाईंको कभरेजको बारेमा थप जान्नको लागि हामीलाई कल गर्नुहोस्।